Observational studyThoracic cancer2019

Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non-small cell lung cancer harboring an EGFR mutation: A prospective observational study.

Taihei Ono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.